Muscle fatigue caused by physical training is understood as a condition related to the inability to maintain action potential, derived from the alteration in skeletal muscle homeostasis. In long-distance recreational runners, prolonged physical work is performed while maintaining the level of intensity, where a level of fatigue intervenes, which overlaps and generates tiredness to execute the movement continuously. In the last 10 years, sports supplementation has been explored as an aid to increase physical performance, improve muscle recovery and prevent sports injuries.
Objective: To analyze the effects of an 8-week training program (TP) with vitamin D and branched-chain amino acids (BCAA) supplementation on physical performance and biomarkers of muscle fatigue in long-distance recreational runners. Materials and methods: An 8-week randomized controlled clinical trial. Participants will be 64 men aged 25 to 44 years, distributed into 4 intervention groups. Group A: Training + BCAA + Vitamin D. Group B: Training + BCAA + Placebo. Group C: Training + Vitamin D + Placebo. Group D: Training + Placebo + Placebo. Biomarkers of muscle fatigue Interleukin 6 (L-6), Creatine Kinase (CK), Lactate (Lact), Testosterone and Cortisol ratio and serum vitamin D (25(OH)D) and physical performance will be assessed by estimating Maximal oxygen consumption (VO2max) and (Maximal aerobic speed) MAS.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Enrollment
64
Aerobic training program (60-90% of maximum aerobic speed)
Branched-chain amino acids (5 gr/day)
Vitamin D (1000 IU/day)
Placebo 1 (5gr/day)
Placebo 2 (1 tablet/day)
Universidad de Colima
Colima, Colima, Mexico
Changes in lactate levels compared to the placebo group
mMol/L
Time frame: 8 weeks
Changes in interleukin-6 levels compared to the placebo group
pg/ml
Time frame: 8 weeks
Changes in cratine kinase levels compared to the placebo group
U/L
Time frame: 8 weeks
Changes in testosterone cortisol ratio compared to the placebo group
mcg/dL
Time frame: 8 weeks
Changes in maximal aerobic speed compared to the placebo group
km/h
Time frame: 8 weeks
Changes in maximal oxygen consumption compared to the placebo group
ml.O2.kg/min
Time frame: 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.